Eric M. Dube, CEO: Travere Therapeutics TVTX Sell · Filed 04/02

Trade details

Type: Insider sale
Amount: $1,066,256.1
Shares · price: 34,902 sh · $30.55 a share
Held after: 457,984 sh
Stock: Travere Therapeutics TVTX
Person: Eric M. DubeCEO
Trade date: 26/04/01
Filed: 26/04/02
Days to filing: 1 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Eric M. Dube's recent trades

Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.9M
108,493 sh
$6.9M
Filed 09/17
Traded 09/17
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$12.2M
195,841 sh
$12.2M
Filed 09/16
Traded 09/16
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
95,666 sh
$6.3M
Filed 09/15
Traded 09/15
Eric M. DubeCEO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06

Eric M. Dube, CEO — sold $1.1M of Travere Therapeutics TVTX · 7.1% of holdings · 10b5-1 plan | Whalegun